Sort
261,768 grants matching “gene therapy”
Stem cells for therapeutics discovery in genetic blood disorders
$1,223,081George Q Daley · Boston Children'S Hospital · U01 · FY2021 · HL
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
$1,222,953Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · NS
Transgenic Mouse Model for Mental Disorders including schizophrenia
$1,222,831Jingshan Chen · National Institute Of Mental Health · Z01 · FY2008 · MH
Inherited Ocular Diseases
$1,222,301James F. Hejtmancik · National Eye Institute · ZIA · FY2015 · EY
Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance
$1,222,203John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,222,182Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2020 · AI
Rhythmicity and Synchrony in the Basal Ganglia
$1,222,179Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2009 · NS
PREQUEL Study In PRE-manifest HD of CoQ10/UbiquinonE Leading to Preventive Trials
$1,221,991Christopher A Ross · Johns Hopkins University · R01 · FY2010 · NS
Expansion of Cardiac and Hematopoietic Pregenitors by Wnt and Notch
$1,221,784Irwin Bernstein · Fred Hutchinson Cancer Research Center · U01 · FY2009 · HL
The connection of innate and adaptive anti-cancer immunity
$1,221,774John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Genetics and Molecular Biology of Parkinsonism
$1,221,769Dennis William Dickson · Mayo Clinic Jacksonville · P50 · FY2016 · NS
A platform for T-cell receptor mimic antibody generation modeled using pHLA-A*11:01 KRAS G12D
$1,221,746Michael P Weiner · Precision Biotools Inc · R44 · FY2025 · GM
GENE TRANSFER TO PROGENITOR AND DIFFERENTIATED CELLS
$1,221,702Weill Medical College Of Cornell Univ · P50 · FY2000 · HL
Preclinical toxicology and pharmacology evaluation of a newTNFR2 antagonistic monoclonal antibody for CTCL therapy
$1,221,684Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2023 · CA
SEARCH FOR SELECTIVE THERAPY OF CML
$1,221,303Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
In vivo single-cell analysis of Alzheimer's disease-associated regulatory elements
$1,221,276Hyejung Won · Univ Of North Carolina Chapel Hill · R61 · FY2025 · AG
Molecular and Cellular Therapies for Muscular Dystrophy
$1,221,198Stanley C Froehner · University Of Washington · P01 · FY2012 · NS
TissueReM: Whole-Organism, Real-time Decision-enabled 3D Tissue Imaging and Recovery for Molecular Analysis
$1,221,189Madhusudhana Gargesha · Bioinvision, Inc. · R44 · FY2025 · GM
Clinical Trial Readiness for SCA1 and SCA3
$1,221,189Tetsuo Ashizawa · Methodist Hospital Research Institute · U01 · FY2020 · NS
Dynamic regulatory network models of human response to influenza virus
$1,221,095Ivan Marazzi · Icahn School Of Medicine At Mount Sinai · U01 · FY2021 · AI
Pathogenesis and Chemotherapy of Human Virus Infections
$1,221,087Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
New York Obesity Research Center
$1,221,081Rudolph L Leibel · Columbia University Health Sciences · P30 · FY2023 · DK
New York Obesity Research Center
$1,221,081Rudolph L Leibel · Columbia University Health Sciences · P30 · FY2022 · DK
New York Obesity Research Center
$1,221,081Dympna Gallagher · Columbia University Health Sciences · P30 · FY2024 · DK
New York Obesity Research Center
$1,221,081Dympna Gallagher · Columbia University Health Sciences · P30 · FY2025 · DK